Dimensional Fund Advisors
STAB

Dimensional Fund Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Dimensional Fund Advisors’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-873
Closed -$8K – 3572
2014
Q2 		$8K Sell
873
-55
-6% -$643 ﹤0.01% 3546
2014
Q1 		$13K Hold
928
– – ﹤0.01% 3529
2013
Q4 		$22K Hold
928
– – ﹤0.01% 3466
2013
Q3 		$29K Sell
928
-70
-7% -$2.31K ﹤0.01% 3476
2013
Q2 		$32K Buy
+998
New +$34.4K ﹤0.01% 3466

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's STAB Position: Q3 2014 in Review

Dimensional Fund Advisors sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2014, closing a stake of 873 shares — an estimated $8K sold.

Dimensional Fund Advisors first reported a position in STAB in Q2 2013 and held it in 5 quarters. The position peaked at $32K in Q2 2013. 25 funds tracked by Wall St. Rank hold STAB as of Q3 2014.

  • Dimensional Fund Advisors reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Dimensional Fund Advisors sold 873 Statera Biopharma, Inc. Common Stock shares in Q3 2014, an estimated $8K.
  • Dimensional Fund Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • Dimensional Fund Advisors's Statera Biopharma, Inc. Common Stock position peaked at $32K in Q2 2013.
  • 25 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2014.

Based on Dimensional Fund Advisors's 13F filing for Q3 2014, filed 13 Nov 2014.